KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Cost of Revenue (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Cost of Revenue data on record, last reported at $432.5 million in Q4 2025.

  • For Q4 2025, Cost of Revenue fell 49.63% year-over-year to $432.5 million; the TTM value through Dec 2025 reached $1.6 billion, up 8.27%, while the annual FY2025 figure was $1.6 billion, 8.27% up from the prior year.
  • Cost of Revenue reached $432.5 million in Q4 2025 per IDXX's latest filing, up from $421.9 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $858.6 million in Q4 2024 and bottomed at -$304.0 million in Q3 2023.
  • Average Cost of Revenue over 5 years is $299.8 million, with a median of $337.3 million recorded in 2021.
  • The widest YoY moves for Cost of Revenue: up 592.75% in 2023, down 190.73% in 2023.
  • A 5-year view of Cost of Revenue shows it stood at $557.7 million in 2021, then tumbled by 38.39% to $343.6 million in 2022, then tumbled by 58.67% to $142.0 million in 2023, then skyrocketed by 504.52% to $858.6 million in 2024, then plummeted by 49.63% to $432.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $432.5 million in Q4 2025, $421.9 million in Q3 2025, and $633.6 million in Q2 2025.